Murine anti-CD6 mAB combined with oral insulin can reverse T1D in the mouse NOD model after the onset of the disease [9]; however, the effect of a humanized anti-CD6 monoclonal antibody combined with insulin on the function of beta cells in T1D patients has not been previously assessed. This evidence concerns the gene INS and type 1 diabetes mellitus.